MedPath

西安京西双鹤药业有限公司

Ownership
-
Established
2002-01-18
Employees
-
Market Cap
-
Website
http://www.jxdcpc.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

74

NMPA:74

Drug Approvals

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20244153
Approval Date
Jun 25, 2024
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H61020004
Approval Date
Apr 10, 2024
NMPA

Ganciclovir and Glucose Injection

Product Name
了凡
Approval Number
国药准字H61020005
Approval Date
Apr 10, 2024
NMPA

Sodium Ferulate and Glucose Injection

Product Name
精欣
Approval Number
国药准字H20061129
Approval Date
Apr 10, 2024
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20233725
Approval Date
Jun 14, 2023
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20237038
Approval Date
Apr 13, 2023
NMPA

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Product Name
盐酸莫西沙星氯化钠注射液
Approval Number
国药准字H20233413
Approval Date
Apr 4, 2023
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20237018
Approval Date
Feb 10, 2023
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20058664
Approval Date
Apr 29, 2021
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20058665
Approval Date
Apr 29, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.